This article is part of the supplement: The role of IFN alpha in autoimmune disease

Review

Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus

Yihong Yao*, Brandon W Higgs, Laura Richman, Barbara White and Bahija Jallal

Arthritis Research & Therapy 2010, 12(Suppl 1):S6 doi:10.1186/ar2887

Accesses  

  • Last 30 days: 96 accesses
  • Last 365 days: 1166 accesses
  • All time: 4506 accesses

Cited by

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations